710-1278

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
710 (USA) · Dr. Silva
consented 2012-12-24

AEs

Serious

Dropout signal

–

Adverse events

mild assessed

Mild APPLICATION SITE ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-02-24 (study day 63.0); relationship: POSSIBLE

mild assessed

Mild APPLICATION SITE ERYTHEMA — outcome: RECOVERED/RESOLVED; onset 2013-02-24 (study day 63.0); relationship: POSSIBLE

moderate assessed

Moderate BURNING SENSATION — outcome: RECOVERED/RESOLVED; onset 2013-02-24 (study day 63.0); relationship: POSSIBLE

mild assessed

Mild RASH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-02-07 (study day 46.0); relationship: POSSIBLE

mild assessed

Mild RASH — outcome: RECOVERED/RESOLVED; onset 2013-02-07 (study day 46.0); relationship: POSSIBLE

mild assessed

Mild SOMNOLENCE — outcome: RECOVERED/RESOLVED; onset 2013-01-13 (study day 21.0); relationship: REMOTE

mild assessed

Mild VOMITING — outcome: RECOVERED/RESOLVED; onset 2013-03-02 (study day 69.0); relationship: REMOTE

Data queries

No data queries.